Nephrostomy Devices Market size valued at around US$ 1.5 bn by 2026

Share this news:

The global nephrostomy devices market size is estimated to reach at US$ 1.5 billion by 2026, Registering a CAGR of 7.6% from 2019 to 2026, according to a new study by Acumen Research and Consulting.

The "Nephrostomy Devices Market (By Product: Nephrostomy Catheters, Guidewires, Sheath Dilators, Drainage Tubes, Others; By End Use: Emergency Clinics, Hospitals, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026" report has been added to Acumen Research and Consulting's offers.

A greater awareness of the nephrostomy machines among doctors is driving the market, along with increasing instances of kidney stone illness. Another main factor in fuelling market growth is an increase in the incidence of ovarian, brown and prostate cancer and an improving healthcare infrastructure in developing countries.

The largest market share in North America is anticipated due to the increased incidence of kidney stone and ovarian, liver and prostate cancers. For example, in 2018, about 22,240 new cases of ovarian cancer were diagnosed in the USA, according to the American Cancer Society. In this industry, major businesses emphasize product launches and innovations in current products. Cook Medical, for example, launched the Universa and the two urinary drainage sets in February 2017.

The increasing popularity of percutaneous nephrostomy processes (PCN) is a main factor in the development of the worldwide nephrostomy device industry. Traditional open-label operations require a number of complications, leading to enhanced demand for minimally invasive operations such as PCN. PCN is a minimally invasive procedure for the treatment of obstruction in the upper urinary tract. This procedure is used for patients with kidney stones of more than 2 cm in size as first-line treatment. The incision is around 1 cm lower and leads to quicker regeneration and shorter hospitalizations.

Over the years, ovarian, kidney stone, bladder and prostate cancer have considerably improved incidence. As a consequence, in a number of nations, governments and private organisations, underline the benefits of nephrostomy systems, while minimizing the composition of therapy costs. Similarly different sellers focus on projects that raise awareness of nephrostomy instruments. The development of the nephrostomy device industry is anticipated to propel such projects during the predicted era.

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1506

The increased incidence of kidney stone is the main driving factor in the worldwide market growth for nephrostomy products. In addition, the increased incidence of ovarian, bladder, prostate cancer, and other diseases are some of the prominent drivers of development in the market for nephrostomy instruments in patients who have been transplanted to kidney. Alternative processes such as ureteral stenting and percutaneous nephrostomy difficulties, however, are factors which hinder worldwide market development of nephrostomy instruments.

Key Findings

The segment guidewires resulted the world market in the nephrostomy industry in 2018 and is planned to grow further from 2019 to 2026 at the lowest CAGR.

The segment development is caused by increased instances of diseases of the kidney and urine and by less invasive guide wires.

2018 was dominated by the hospital segment. Percutaneous nephrostomy in most hospitals is conducted in comparison with emergency clinics, driving development in the segment.

The ASC segment is expected to record the largest CAGR because ASC's nephrostomy systems, such as important cost conservation and customized services, have been commonly used by ASC.

North America is the market leader because of a large number of targets, the accessibility of expert surgeons, a well-established health industry and the rapid use of sophisticated healthcare instruments.

Key Players & Strategies

Cardinal Health; Teleflex, Inc.; Becton, Argon Medical; Boston Scientific Corp.; Dickinson and Company; Cook Medical; Coloplast Group; B. Braun Melsungen AG; Olympus Corp.; and Uresil LLC are major firms in the market, with a greater focus on the new product development, technological progress and M&A, to enhance their position on the worldwide market. Cook Medical, for example, started Universa together with two percutaneous urinary drainage sets in February 2017. The brand involves foley and ureteral catheters in various configurations and sizes to satisfy doctors and patients ' particular reference and needs.

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1506

The Major Market Segments of the Global Nephrostomy Devices Market are as below:

Market, By Product

Nephrostomy Catheters
Guidewires
Sheath Dilators
Drainage Tubes
Others

Market, By End Use

Emergency Clinics
Hospitals
Ambulatory Surgical Centers

Market, By Geography

North America.
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)

The market research study on “Nephrostomy Devices Market 2019 - 2026” offers detailed insights on global Nephrostomy Devices market segments with market dynamics and their impact. The report also covers basic technology development policies.

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1506

Contact Info:
Name: Frank Wilson
Email: Send Email
Organization: Acumen Research and Consulting
Address: 17890, Castleton St #218, Rowland Heights, CA 91748 United States
Phone: 4079154157
Website: https://www.acumenresearchandconsulting.com

Release ID: 88915243

CONTACT ISSUER
Name: Frank Wilson
Email: Send Email
Organization: Acumen Research and Consulting
Address: 17890, Castleton St #218, Rowland Heights, CA 91748 United States
SUBSCRIBE FOR MORE